DZ2544A1 - Formes posologiques de sertraline et procédé pour leur préparation. - Google Patents

Formes posologiques de sertraline et procédé pour leur préparation.

Info

Publication number
DZ2544A1
DZ2544A1 DZ980154A DZ980154A DZ2544A1 DZ 2544 A1 DZ2544 A1 DZ 2544A1 DZ 980154 A DZ980154 A DZ 980154A DZ 980154 A DZ980154 A DZ 980154A DZ 2544 A1 DZ2544 A1 DZ 2544A1
Authority
DZ
Algeria
Prior art keywords
sertraline
preparation
dosage forms
dosage
forms
Prior art date
Application number
DZ980154A
Other languages
English (en)
French (fr)
Inventor
William John Curatolo
Ravi Mysore Shanker
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2544(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ2544A1 publication Critical patent/DZ2544A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DZ980154A 1997-07-01 1998-06-30 Formes posologiques de sertraline et procédé pour leur préparation. DZ2544A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
DZ2544A1 true DZ2544A1 (fr) 2003-02-08

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980154A DZ2544A1 (fr) 1997-07-01 1998-06-30 Formes posologiques de sertraline et procédé pour leur préparation.

Country Status (40)

Country Link
EP (1) EP0980241B1 (uk)
JP (1) JP3585245B2 (uk)
KR (1) KR100371730B1 (uk)
CN (1) CN1261792A (uk)
AP (1) AP945A (uk)
AR (1) AR015916A1 (uk)
AT (1) ATE256457T1 (uk)
AU (1) AU724635B2 (uk)
BG (1) BG103917A (uk)
BR (1) BR9809712A (uk)
CA (1) CA2290973C (uk)
CO (1) CO4940405A1 (uk)
DE (1) DE69820608T2 (uk)
DK (1) DK0980241T3 (uk)
DZ (1) DZ2544A1 (uk)
EA (1) EA001905B1 (uk)
ES (1) ES2210760T3 (uk)
GT (1) GT199800090A (uk)
HR (1) HRP980378B1 (uk)
HU (1) HUP0002250A3 (uk)
ID (1) ID24673A (uk)
IL (1) IL133075A0 (uk)
IS (1) IS5266A (uk)
MA (1) MA24586A1 (uk)
MY (1) MY119728A (uk)
NO (1) NO996492L (uk)
NZ (1) NZ501252A (uk)
OA (1) OA11246A (uk)
PA (1) PA8454001A1 (uk)
PE (1) PE97299A1 (uk)
PL (1) PL337807A1 (uk)
PT (1) PT980241E (uk)
SK (1) SK282914B6 (uk)
TN (1) TNSN98123A1 (uk)
TR (1) TR199903282T2 (uk)
TW (1) TW382597B (uk)
UA (1) UA68350C2 (uk)
UY (1) UY25070A1 (uk)
WO (1) WO1999001113A1 (uk)
ZA (1) ZA985709B (uk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2001002119A0 (en) * 1998-10-13 2001-03-22 Pfizer Prod Inc Sertraline oral concentrate.
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
ES2256032T3 (es) 1999-09-03 2006-07-16 Apbi Holdings, Llc Utilizacion de dapoxetina, un inhibidor selectivo de la recaptacion de serotonina, para el tratamiento de una disfuncion sexual.
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
EP1375659A1 (en) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
CN1728982A (zh) * 2002-10-31 2006-02-01 阿尔扎公司 可增加疏水性药物生物利用度的药物制剂
WO2016020936A2 (en) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0782445T3 (da) * 1994-09-19 2002-05-06 Bristol Myers Squibb Pharma Co Kombination af en opioidantagonist og en selektiv serotoningenoptagelsesinhibitor til behandling af alkoholisme og alkoholafhængighed
EP0768083B1 (en) * 1995-07-17 2003-03-26 Pfizer Inc. Sertraline for treating post myocardial infarction patients

Also Published As

Publication number Publication date
AP945A (en) 2001-02-28
ID24673A (id) 2000-07-27
DE69820608T2 (de) 2004-12-23
PT980241E (pt) 2004-03-31
UA68350C2 (en) 2004-08-16
JP2000512316A (ja) 2000-09-19
CN1261792A (zh) 2000-08-02
PE97299A1 (es) 1999-10-13
GT199800090A (es) 1999-12-21
MY119728A (en) 2005-07-29
NZ501252A (en) 2004-11-26
HUP0002250A2 (hu) 2000-12-28
PL337807A1 (en) 2000-09-11
OA11246A (en) 2002-11-19
DE69820608D1 (de) 2004-01-29
AR015916A1 (es) 2001-05-30
NO996492L (no) 2000-02-29
TR199903282T2 (xx) 2000-08-21
TNSN98123A1 (fr) 2005-03-15
MA24586A1 (fr) 1998-12-31
ZA985709B (en) 2000-01-10
HUP0002250A3 (en) 2001-01-29
EP0980241A1 (en) 2000-02-23
KR20010013588A (ko) 2001-02-26
CO4940405A1 (es) 2000-07-24
CA2290973C (en) 2003-06-17
HRP980378B1 (en) 2001-12-31
JP3585245B2 (ja) 2004-11-04
EA199900963A1 (ru) 2000-08-28
SK282914B6 (sk) 2003-01-09
PA8454001A1 (es) 2000-05-24
CA2290973A1 (en) 1999-01-14
DK0980241T3 (da) 2004-04-05
TW382597B (en) 2000-02-21
BR9809712A (pt) 2000-07-11
WO1999001113A1 (en) 1999-01-14
EP0980241B1 (en) 2003-12-17
UY25070A1 (es) 2000-12-29
AP9801279A0 (en) 1998-06-30
KR100371730B1 (ko) 2003-02-07
HRP980378A2 (en) 1999-04-30
NO996492D0 (no) 1999-12-27
ATE256457T1 (de) 2004-01-15
IL133075A0 (en) 2001-03-19
IS5266A (is) 1999-11-23
AU724635B2 (en) 2000-09-28
SK180599A3 (en) 2001-01-18
AU7545098A (en) 1999-01-25
BG103917A (bg) 2000-07-31
ES2210760T3 (es) 2004-07-01
EA001905B1 (ru) 2001-10-22

Similar Documents

Publication Publication Date Title
DZ2546A1 (fr) Sels de sertraline et formes posologiques de sertraline à libération prolongée et procédé pour leur préparation.
DZ2923A1 (fr) Formulations pharmaceutiques d'inhibiteurs de pde-5 de gmpc à libération contrôlée, et procédé pour leur préparation.
MA26536A1 (fr) Association de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation.
DZ2186A1 (fr) Compositions pharmaceutiques mixtes pour le traitement de l'ostéoporose et procédé pour leur préparation.
DZ2596A1 (fr) Associations pharmaceutiques d'amlodipine et d'atorvastatine et procédé pour leur préparation.
DZ2523A1 (fr) Formulations pharmaceutiques contenant du voriconazole et procédé pour leur préparation.
DZ2634A1 (fr) Dérivés de pleuromutiline nouveaux procédé pour leur préparation et compositions pharmaceutiques lescontenant.
EG23978A (fr) Composition pharmaceutique de, benofibrate presentant une biodisponibilite elevee et son procede de preparation
DZ2197A1 (fr) Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2358A1 (fr) Amides inhibiteurs de sécrétion de apo b/mtp procédé pour leur préparation et compositions pharmaceutiques les contenant
DZ2600A1 (fr) Associations pharmaceutiques d'amlodipine et d'unestatine et procédé pour leur préparation.
FR2722984B1 (fr) Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
DZ2045A1 (fr) Amides thérapeutiques, procédé pour leur préparation et compositions les contenant.
DZ2777A1 (fr) Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2498A1 (fr) Dérivés de quinoléine nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2702660B1 (fr) Compositions thérapeutiques stabilisées et leur procédé de préparation.
DZ1946A1 (fr) Procédé pour la préparation de supports.
DZ2544A1 (fr) Formes posologiques de sertraline et procédé pour leur préparation.
FR2716881B1 (fr) Procédé de préparation et de purification d'Iopamidol.
DZ2658A1 (fr) Formulations nouvelles de paroxétine et procédé pour leur préparation.
MA23663A1 (fr) Procede de preparation de formulations pharmaceutiques
FR2720397B1 (fr) Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment.
DZ2677A1 (fr) Compositions nouvelles renfermant des dérivés de benzopyranne et pyridopyranne et procédé pour leur préparation.
DZ2309A1 (fr) Dérivés de pyrrolidinyl-et pyrrolinyl-éthylamine procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3083A1 (fr) Composés nouveaux inhibiteurs de protéases, procédé pour leur préparation et compositions pharmaceutiques les conentant.